Skip to content

DALI: Lifestyle pilot

DALI: Lifestyle pilot - DALI Lifestyle pilot

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38179
Enrollment
12
Registered
2011-06-06
Start date
2011-11-28
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational diabetes

Interventions

In the programme, one-to-one contact will be offered, along with telephone booster calls. The same amount of time will be offered to each participant during the trial. The intervention will be provi

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - prepregnancy BMI (self-reported weight, measured height) is >

Exclusion criteria

Exclusion criteria: - Pre-existing diabetes - diagnosed with (gestational) diabetes mellitus before randomisation, defined as fasting glucose >=5.1 mmol/l and/or 1 hour glucose >= 10 mmol/l and/or 2 hour glucose *8.5 mmol/l at baseline measurement. - not able to walk at least 100 meters safely - requirement for complex diets - advanced chronic conditions (eg valvular heart disease) - significant psychiatric disease - known abnormal calcium metabolism (hypo/hyperparathyroidism, nephrolithiasis,hypercalciuria) or hypercalciuria detected at screening (0.6 mmol/mmol creatinine in spot morning urine) - twin pregnancy

Design outcomes

Primary

MeasureTime frame
In order to achieve the research goals, the participants will be requested to fill out an evaluation questionnaire at the end of the lifestyle intervention. It consists of questions about time, cost, comprehensibility, lay-out and completeness concerning the different segments of the intervention such as the online baseline questionnaire, the tailored lifestyle advice, the face-to-face coaching session, the telephone coaching sessions, the measurements by the research assistant and the communication with the research team. For example *How much time did it take to fill out the baseline questionnaire? Do you think this is acceptable or non acceptable?* *How clear do you think the questions of the baseline questionnaire were? (1) unclear - (2) - (3) - (4) - (5) clear.*

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)